Pattern of changes in liver enzymes SGPT, SGOT level during Dengue infection in hospitalized pediatrics patients in tertiary care centre

Authors

  • Nazeer Ahmad Jeergal Department of Paediatrics, Al Ameen Medical College, Athani Road, Vijaypur, Karnataka, India
  • Riyaz Ahmed F. K. Department of Paediatrics, Vijayanagar Institute of Medical Sciences, Cantonment Ballari, Karnataka, India
  • Riyaz Ahmed F. K. Department of Paediatrics, Vijayanagar Institute of Medical Sciences, Cantonment Ballari, Karnataka, India
  • Ayesha Siddiqa Department of Paediatrics, Al Ameen Medical College, Athani Road, Vijaypur, Karnataka, India
  • Ayesha Siddiqa Department of Paediatrics, Al Ameen Medical College, Athani Road, Vijaypur, Karnataka, India
  • Ravindra G. Naganoor Department of Paediatrics, Al Ameen Medical College, Athani Road, Vijaypur, Karnataka, India
  • Ravindra G. Naganoor Department of Paediatrics, Al Ameen Medical College, Athani Road, Vijaypur, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20194742

Keywords:

Aminotransferases, Dengue, Liver, Shock

Abstract

Background: Hepatic involvement is not an uncommon in dengue viral infection, which presents with elevation in serum aminotransferases due to reactive hepatitis. The study is aimed to know the pattern of changes in hepatic enzyme levels in dengue infection in pediatric patients and to assess it with clinical presentation of dengue in particularly patients without and with shock.

Methods: Pediatric patients with serologically confirmed Dengue viral infection were enrolled in the study and divided clinically into a shock group and a non-shock group. SGPT and SGOT levels were measured from day one of fever onset till 7 days and within 3 days after shock in the shock group. Student t-test was used to analyze the statistical data.

Results: 100 patients with a mean age of 8±2.6 years were included in the study. The incidence of abnormal SGOT and SGPT levels were 96.9% and 51.1% in the shock group, and 92.2% and 45% in the non-shock group respectively. 30% and 17.9% of the patients in shock group and only 9.9% and 4.2% in non-shock group had the respective SGOT and SGPT levels > 200 U/L. Patients in shock group had statistically higher levels of Serum aminotransferase compared to the non-shock group. SGOT tended to increase starting from one day before shock and continued to increase within a few days whereas SGPT was less likely to be affected.

Conclusions: Pediatric patients with Dengue infection have raised Aminotransferases in particular SGOT, which is higher than SGPT level. Aminotransferase levels in shock patients are significantly high and increases up to 3 days.

References

Seneviratne SL, Malavige GN, De Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg. 2006;100(7):608-14.

Lum LC, Lam SK, George R, Devi S. Fulminant hepatitis in dengue infection. Southeast Asian J Trop Med Public Health. 1993;24(3):467-71.

Lin YL, Liu CC, Lei HY, Yeh TM, Lin YS, Chen RM, et al. Infection of five human liver cell lines by dengue‐2 virus. J Medical Virol. 2000;60(4):425-31.

Paes MV, Lenzi HL, Nogueira AC, Nuovo GJ, Pinhao AT, Mota EM, et al. Hepatic damage associated with dengue-2 virus replication in liver cells of BALB/c mice. Lab Invest. 2009;89(10):1140-51.

Pancharoen C, Rungsarannont A, Thisyakorn U. Hepatic dysfunction in dengue patients with various severity. J Medical Assoc Thailand Chotmaihet Thangphaet. 2002;85:S298-301.

Gulati S, Maheshwari A. Atypical manifestations of dengue. Tropical Med Int Health. 2007;12(9):1087-95.

Wang LY, Chang WY, Lu SN, Chen TP. Sequential changes of serum transaminase and abdominal sonography in patients with suspected dengue fever. Gaoxiong yi xue ke xue za zhi Kaohsiung J Medical Sci. 1990;6(9):483-9.

WHO. Dengue guidelines for diagnosis, prevention and control, New edition Ed. Southeast Asian Office of the WHO World Health Organisation;2009.

Poovorawan Y, Hutagalung Y, Chongsrisawat V, Boudville I, Bock HL. Dengue virus infection: a major cause of acute hepatic failure in Thai children. Ann Tropical Paediatr. 2006;26(1):17-23.

Singh S, Meena JK, Verma CR, Bhaskar V. A hospital-based study of hepatic dysfunction in children with dengue fever. Asian Pacific Journal of Tropical Disease. 2015;5(12):964-7.

Petdachai W. Hepatic Dysfunction in Children with Dengue Shock Syndrome. Dengue Bulletin. 2005;29:112-8.

Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P, Chakraborty S. Profile of hepatic involvement by dengue virus in dengue infected children. North Am J Med Sci. 2013;5(8):480-5.

Jagadishkumar K, Jain P, Manjunath VG, Umesh L. Hepatic involvement in dengue fever in children. Iranian J Pediatr. 2012;22(2):231-36.

Nimmannitya S, Thisyakorn U, Hemsrichart V. Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J Tropical Med Public Health. 1987;18(3):398-406.

Mahmuduzzaman M, Chowdhury AS, Ghosh DK, Kabir IM, Rahman MA, Ali MS. Serum transaminase level changes in dengue fever and its correlation with disease severity. Mymensingh Medical J. 2011;20(3):349-55.

Azin FR, Gonçalves RP, Pitombeira MH, Lima DM, Castelo Branco I. Dengue: profile of hematological and biochemical dynamics. Revista brasileira de hematologia e hemoterapia. 2012;34(1):36-41.

Downloads

Published

2019-10-21

Issue

Section

Original Research Articles